Titre :
  • Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
Auteur : Perner, Anders ; Haase, Nicolai ; Guttormsen, Anne B ; Tenhunen, Jyrki ; Klemenzson, Gudmundur ; Åneman, Anders ; Madsen, K. ; Møller, Morten H ; Elkjær, Jeanie M ; Poulsen, Lone M ; Bendtsen, Asger ; Winding, Robert ; Steensen, Morten ; Berezowicz, Pawel ; Søe-Jensen, Peter ; Bestle, Morten ; Strand, Kristian ; Wiis, Jørgen ; White, J.O. ; Thornberg, Klaus J ; Quist, Lars ; Nielsen, Jonas ; Andersen, Ulrik Lund ; Holst, Lars B ; Thormar, Katrin ; Kjældgaard, Anne-Lene ; Fabritius, Maria L ; Mondrup, Frederik ; Pott, Frank C ; Møller, Thea P ; Winkel, Per ; Wetterslev, Jørn ; De Backer, Daniel
Informations sur la publication : The New England journal of medicine, 367, 2, (page 124-134)
Statut de publication : Publié, 2012-07
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Aged
Double-Blind Method
Female
Fluid Therapy -- adverse effects -- methods
Hemorrhage -- chemically induced
Humans
Hydroxyethyl Starch Derivatives -- adverse effects -- therapeutic use
Intention to Treat Analysis
Isotonic Solutions -- adverse effects -- therapeutic use
Kidney Failure, Chronic -- etiology -- therapy
Male
Middle Aged
Renal Replacement Therapy
Sepsis -- complications -- mortality -- therapy
Note : Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
6S Trial Group ; Scandinavian Critical Care Trials Group
Langue :
  • Anglais
Identificateurs : urn:issn:0028-4793 
info:doi/10.1056/NEJMoa1204242
info:pmid/22738085